Omega Healthcare Investors, Inc. $OHI Shares Sold by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. reduced its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHIFree Report) by 20.2% in the 4th quarter, HoldingsChannel reports. The fund owned 2,440,207 shares of the real estate investment trust’s stock after selling 617,824 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Omega Healthcare Investors were worth $108,199,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. CPC Advisors LLC acquired a new position in shares of Omega Healthcare Investors during the 4th quarter worth about $3,050,000. JPMorgan Chase & Co. boosted its position in shares of Omega Healthcare Investors by 77.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,417,240 shares of the real estate investment trust’s stock worth $144,278,000 after acquiring an additional 1,496,059 shares in the last quarter. Bright Futures Wealth Management LLC. acquired a new position in shares of Omega Healthcare Investors during the 3rd quarter worth about $458,000. Pensionfund PDN acquired a new stake in shares of Omega Healthcare Investors in the 4th quarter valued at about $2,053,000. Finally, Oppenheimer Asset Management Inc. boosted its position in shares of Omega Healthcare Investors by 765.0% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 86,651 shares of the real estate investment trust’s stock valued at $3,658,000 after purchasing an additional 76,634 shares during the period. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Down 1.0%

OHI opened at $43.60 on Friday. The business has a 50 day moving average price of $46.28 and a two-hundred day moving average price of $45.72. The company has a quick ratio of 5.32, a current ratio of 5.32 and a debt-to-equity ratio of 0.81. The company has a market cap of $12.98 billion, a PE ratio of 21.06, a P/E/G ratio of 1.90 and a beta of 0.58. Omega Healthcare Investors, Inc. has a 52 week low of $35.70 and a 52 week high of $49.33.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last posted its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.02). The company had revenue of $322.96 million for the quarter, compared to analysts’ expectations of $264.07 million. Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The firm’s revenue was up 16.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.75 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. As a group, research analysts anticipate that Omega Healthcare Investors, Inc. will post 3.07 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, May 4th were paid a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, May 4th. This represents a $2.68 annualized dividend and a yield of 6.1%. Omega Healthcare Investors’s dividend payout ratio is currently 129.47%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Cantor Fitzgerald upped their target price on Omega Healthcare Investors from $50.00 to $52.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. BMO Capital Markets reissued a “market perform” rating and issued a $52.00 target price on shares of Omega Healthcare Investors in a research report on Monday, May 4th. UBS Group upped their target price on Omega Healthcare Investors from $52.00 to $54.00 and gave the company a “buy” rating in a research report on Wednesday, May 13th. Weiss Ratings cut Omega Healthcare Investors from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Tuesday. Finally, Truist Financial upped their target price on Omega Healthcare Investors from $46.00 to $48.00 and gave the company a “hold” rating in a research report on Thursday, March 5th. Six analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $49.17.

Read Our Latest Report on Omega Healthcare Investors

About Omega Healthcare Investors

(Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

Featured Stories

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHIFree Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.